Protalix BioTherapeutics (PLX) Current Deferred Revenue (2010 - 2025)
Protalix BioTherapeutics (PLX) posted Current Deferred Revenue of $2 million for Q1 2025, down 81.9% from $11.04 million a year earlier.
Powered by 
Analysis
Protalix BioTherapeutics (PLX) Current Deferred Revenue (2010 - 2025) Analysis & Trends
At the end of FY2022, Protalix BioTherapeutics' Current Deferred Revenue came in at $13.18 million, up 54.1% from FY2021.
- Annual Current Deferred Revenue shows a four-year compound annual growth rate of 7.5% (FY2018 to FY2022).
- In prior years, Protalix BioTherapeutics' Current Deferred Revenue was $8.55 million in FY2021 (+58.5%), $5.39 million in FY2020 (-67.0%), $16.34 million in FY2019 (+65.5%) and $9.87 million in FY2018.
- The Q1 2025 figure stands as the lowest quarterly Current Deferred Revenue since Q2 2017.
- The strongest year-over-year quarter for Current Deferred Revenue in the past five years was Q1 2022, with growth of 361.0%; the weakest was Q1 2021, with a decline of 86.5%.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn |
| 10 | Protalix BioTherapeutics | 207.16 Mn | 55.78 Mn | 12.13 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2025 | 2.00 Mn |
| Jun 30, 2024 | 12.70 Mn |
| Mar 31, 2024 | 11.04 Mn |
| Mar 31, 2023 | 11.79 Mn |
| Dec 31, 2022 | 13.18 Mn |
| Sep 30, 2022 | 14.79 Mn |
| Jun 30, 2022 | 10.22 Mn |
| Mar 31, 2022 | 11.80 Mn |
| Dec 31, 2021 | 8.55 Mn |
| Sep 30, 2021 | 15.16 Mn |
| Jun 30, 2021 | 18.11 Mn |
| Mar 31, 2021 | 2.56 Mn |
| Dec 31, 2020 | 5.39 Mn |
| Sep 30, 2020 | 16.72 Mn |
| Jun 30, 2020 | 18.35 Mn |
| Mar 31, 2020 | 19.01 Mn |
| Dec 31, 2019 | 16.34 Mn |
| Sep 30, 2019 | 11.61 Mn |
| Jun 30, 2019 | 7.54 Mn |
| Mar 31, 2019 | 9.43 Mn |
API Access
Protalix BioTherapeutics Current Deferred Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=PLX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-deferred-revenue", "ticker": "PLX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=PLX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();